What is the current valuation of the US herbal nanomedicine market?

The market valuation was $1520.0 Million in 2024. Read More

What is the projected market size for the US herbal nanomedicine market by 2035?

The market is expected to reach $3750.0 Million by 2035. Read More

What is the expected CAGR for the US herbal nanomedicine market during the forecast period 2025 - 2035?

The expected CAGR is 8.56% during the forecast period. Read More

What is the market valuation for Polymeric Herbal Nanoparticles in 2024?

The market valuation for Polymeric Herbal Nanoparticles was $304.0 Million in 2024. Read More

Which applications are driving growth in the US herbal nanomedicine market?

Applications include Cancer, Cardiovascular Diseases, and Neurological Disorders. Read More

What was the market size for Cancer applications in 2024?

The market size for Cancer applications was $600.0 Million in 2024. Read More

How does the market for Ginseng compare to other sources in the herbal nanomedicine market?

The market for Ginseng was valued at $304.0 Million in 2024, similar to other sources like Turmeric and Aloe Vera. Read More

What is the projected growth for the Solid Lipid Nanoparticles segment by 2035?

The Solid Lipid Nanoparticles segment is projected to grow from $228.0 Million in 2024 to $550.0 Million by 2035. Read More

US Herbal Nanomedicine Market

Q: Which companies are considered key players in the US herbal nanomedicine market?

Key players include NanoBio Corporation, Herbalife Nutrition Ltd, Amgen Inc, and others. Read More

Q: What are the main types of herbal nanomedicine products available in the market?

Main types include Polymeric Herbal Nanoparticles, Solid Lipid Nanoparticles, and Phytosomes. Read More

ID: MRFR/HC/52342-HCR 200 Pages Satyendra Maurya Last Updated: September 17, 2026

US Herbal Nanomedicine Market Research Report By Type (Polymeric Herbal Nanoparticles, Solid Lipid Nanoparticles, Phytosomes, Nano-Micelles, Self-nano Emulsifying Drug Delivery System, Nanofibers, Others), By Source (Ginseng, Turmeric, Aloe Vera, Ginger, Others) and By Application (Cancer, Cardiovascular Diseases, Neurological Disorders, Others) -Forecast to 2035

US Herbal Nanomedicine Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)8.56%

2024 Market Size$ 1,520 Million

2025 Market Size$ 1,650.11 Million

2035 Market Size$ 3,750 Million

Key Players

NanoBio Corporation

Herbalife Nutrition Ltd

Amgen Inc

Bristol-Myers Squibb Company

Bayer AG

Merck KGaA

Trends

Rising Demand for Natural Remedies
Advancements in Nanotechnology
Focus on Personalized Medicine

Opportunities

Increasing Consumer Awareness
Regulatory Support for Herbal Products
Rising Interest in Preventive Healthcare

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Chemicals and Materials, BY Type (USD Million)
  1. 4.1.1 Polymeric Herbal Nanoparticles
  2. 4.1.2 Solid Lipid Nanoparticles
  3. 4.1.3 Phytosomes
  4. 4.1.4 Nano-Micelles
  5. 4.1.5 Self-nano Emulsifying Drug Delivery System
  6. 4.1.6 Nanofibers
  7. 4.1.7 Others
2. 4.2 Chemicals and Materials, BY Source (USD Million)
  1. 4.2.1 Ginseng
  2. 4.2.2 Turmeric
  3. 4.2.3 Aloe Vera
  4. 4.2.4 Ginger
  5. 4.2.5 Others
3. 4.3 Chemicals and Materials, BY Application (USD Million)
  1. 4.3.1 Cancer
  2. 4.3.2 Cardiovascular Diseases
  3. 4.3.3 Neurological Disorders
  4. 4.3.4 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 NanoBio Corporation (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Herbalife Nutrition Ltd (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Amgen Inc (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Bristol-Myers Squibb Company (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Bayer AG (DE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Merck KGaA (DE)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 GSK plc (GB)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Pfizer Inc (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TYPE
3. 6.3 US MARKET ANALYSIS BY SOURCE
4. 6.4 US MARKET ANALYSIS BY APPLICATION
5. 6.5 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
6. 6.6 RESEARCH PROCESS OF MRFR
7. 6.7 DRO ANALYSIS OF CHEMICALS AND MATERIALS
8. 6.8 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
9. 6.9 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
10. 6.10 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
11. 6.11 CHEMICALS AND MATERIALS, BY TYPE, 2024 (% SHARE)
12. 6.12 CHEMICALS AND MATERIALS, BY TYPE, 2024 TO 2035 (USD Million)
13. 6.13 CHEMICALS AND MATERIALS, BY SOURCE, 2024 (% SHARE)
14. 6.14 CHEMICALS AND MATERIALS, BY SOURCE, 2024 TO 2035 (USD Million)
15. 6.15 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 (% SHARE)
16. 6.16 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 TO 2035 (USD Million)
17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY SOURCE, 2025-2035 (USD Million)
  3. 7.2.3 BY APPLICATION, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Enquiry

Customize Report

US Herbal Nanomedicine Market Segmentation

US Herbal Nanomedicine Market By Type (USD Million, 2025-2035)

Polymeric Herbal Nanoparticles
Solid Lipid Nanoparticles
Phytosomes
Nano-Micelles
Self-nano Emulsifying Drug Delivery System
Nanofibers
Others

US Herbal Nanomedicine Market By Source (USD Million, 2025-2035)

Ginseng
Turmeric
Aloe Vera
Ginger
Others

US Herbal Nanomedicine Market By Application (USD Million, 2025-2035)

Cancer
Cardiovascular Diseases
Neurological Disorders
Others

Certified Researchers

Enquiry

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”

Guilherme Gomes Martins Product Management Director

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”